Waiting
로그인 처리 중...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Clinical Application of Sleeping Beauty and…
JoVE Journal
Immunology and Infection

이 콘텐츠 오픈 액세스로 구독없이 시청하실 수 있습니다.

JoVE Journal Immunology and Infection
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
 

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Article DOI: 10.3791/50070-v • 09:29 min • February 1st, 2013
February 1st, 2013 •
1, 1, 1, 1, 2, 2, 2, 1, 1
1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center

챕터

요약
Automatic Translation

T cells expressing a CD19-specific chimeric antigen receptor (CAR) are infused as investigational treatment of B-cell malignancies in our first-in-human gene therapy trials. We describe genetic modification of T cells using the Sleeping Beauty (SB) system to introduce CD19-specific CAR and selective propagation on designer CD19+ artificial antigen presenting cells.

Tags

Keywords: Sleeping Beauty Artificial Antigen Presenting Cells Genetic Modification T Cells Peripheral Blood Umbilical Cord Blood CAR T Cells CD19 Gene Therapy Immunotherapy Tumor-associated Antigens Clinical Application
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter